Skip to main content

Table 1 Association of Aur-A expression with clinicopathological parameters

From: Aurora-A down-regulates IkappaBα via Akt activation and interacts with insulin-like growth factor-1 induced phosphatidylinositol 3-kinase pathway for cancer cell survival

Clinicopathological features n Aur-A expression
Positive No.(%)
χ2 P
Age ≤ 60 years 28 20 (71.4) 0.900 0.343
  >60 years 27 16 (59.3)   
Gender Male 33 22 (66.7) 0.054 0.817
  Female 22 14 (63.6)   
Clinical Stage I+II 19 8 (42.1) 6.999 0.008
  III+IV 36 28 (77.8)   
Differentiation Well 7 2 (28.6) 4.952 0.084
  Moderate 26 19 (73.1)   
  Poor 22 15 (68.2)   
Lymph node metastasis Positive 16 14 (87.5) 4.850 0.028
  Negative 39 22 (56.4)